| Part Of Safety of Arthritis Drugs, Day 1,
Report Video IssueSafety of Arthritis Drugs, Day 1, Part 4
2005-02-23T14:36:29-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJkZWZhdWx0c1wvQ2FwaXRvbF9kZWZhdWx0LWltYWdlLmpwZyIsImVkaXRzIjp7InJlc2l6ZSI6eyJmaXQiOiJjb3ZlciIsImhlaWdodCI6NTA2fX19Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Food and Drug Administration. They also responded to questions from members of the committee.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, an… read more
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib, and Naproxen spoke as did representatives for the Food and Drug Administration. They also responded to questions from members of the committee.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close
People in this video
-
- Andrew Dannenberg Director New York Presbyterian Hospital->Cancer Prevention
-
-
-
-
-
-
- Ernest Hawk Director National Institutes of Health->Office of Ctrs.,Training and Resources
-
-
- Martin Huber Vice President Hoffmann-La Roche Inc.->Global
-
-
- Nancy Nussmeier Director Texas Heart Institute->Cardiovascular Medicine
-
-
-
- Lee Simon Physician
-
- Andrew Whelton Professor
- William White Professor University of Connecticut
- James Witter Lead Medical Officer U.S. Food and Drug Administration->Center for Drug Evaluation and Research
-
Hosting Organization
More Videos From
Safety of Arthritis Drugs, Day 1,
More Videos
Purchase a Download
Safety of Arthritis Drugs, Day 1, Part 4
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Presidential Radio Address
In his weekly radio address President Bush talked about the May 15 deadline for signing up for the new Medicare prescrip…
-
Prescription Drug Safety
Food and Drug Administration Commissioner Andrew C. von Eschenbach talked about efforts to balance drug safety, risk, be…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional ove…
-
Comfortably Numb: Open Phones
Charles Barber responded to telephone calls from viewers about his book Comfortably Numb: How Psychiatry Is Medicating a…